The estimation of chemotherapeutic pathomorphosis of non-small cell lung cancer.

The estimation of chemotherapeutic pathomorphosis of non-small cell lung cancer.

The aim of the study was the investigation of therapeutic pathomorphosis (ThP) of non-small cell lung cancer (NSCLC) and device the method of its estimation. In the context of investigation there were 152 patients with IIIA st. NSCLC, being treated with ICT (102 pts) and without it (50 pts). The ana...

Full description

Bibliographic Details
Main Authors:	Sukhoversha O.A., Bilen’kiy I.V., Chekan S.M., Kosse V.A.
Format:	Article
Language:	Russian
Published:	Ministry of Health of Ukraine. Dnipropetrovsk Medical Academy 2007-01-01
Series:	Морфологія
Subjects:	: non-small cell lung cancer therapeutic pathomorphosis induction chemotherapy
Online Access:	http://www.morphology.dp.ua/_pub/MORPHO-2007-01-02/07soanrl.pdf

Similar Items

Therapeutic pathomorphosis of advanced NSCLC as a criteria for effectiveness of induction chemotherapy.
by: Kosse V.A., et al.
Published: (2007-01-01)

The correlation between clinical and pathomorphological effects of induction chemotherapy and long-term results of multimodality treatment for IIIA st. NSCLC.
by: Sukhoversha O.A.
Published: (2007-01-01)

Pathomorphological prognostic factors as the basis of optimization for multimodality treatment of IIIA stage of non-small cell lung cancer.
by: Sukhoversha O.A.
Published: (2007-01-01)

PATHOMORPHOSIS IN THE CLINICAL PICTURE OF NEUROSYPHILIS
by: Kolokolov O.V., et al.
Published: (2012-06-01)

Manifestations of pathomorphosis at pregnant women with heart diseases
by: Kazachkova E.A., et al.
Published: (2017-06-01)

Tumor downstaging and therapeutic pathomorphosis in rectal cancer patients receiving combination therapy with various polyradiomodification regimens
by: O. A. Vlasov, et al.
Published: (2018-07-01)

Polyradiomodification in combined treatment for rectal cancer and the role of therapeutic pathomorphosis
by: Yu. A. Barsukov, et al.
Published: (2018-05-01)

FOCAL EPILEPSIES: PATHOMORPHOSIS TYPES
by: M. G. Amirkhanian, et al.
Published: (2017-12-01)

Pathomorphosis of stage IIB cervical cancer in preoperative radiation therapy
by: A.E. Kryzhanivska, et al.
Published: (2013-08-01)

Therapeutic pathomorphosis in malignant glioma tissues after photodynamic therapy with сhlorin e6 (reports of two clinical cases)
by: A. Yu. Rynda, et al.
Published: (2020-07-01)

Pre-operative chemoradiation therapy in complex treatment of patients with locally advanced tumors of the thoracic esophagus
by: M S Shogenov, et al.
Published: (2018-03-01)

Pathomorphosis of main tyropathies (review of literature and own observations)
by: R.P. Liashuk, et al.
Published: (2018-02-01)

Neoadjuvant chemotherapy in the combination treatment for locally advanced rectal cancer: currently available options
by: D. V. Kuzmichev, et al.
Published: (2018-11-01)

Effect of immunoadjuvants on the disease course in patients with operable breast cancer
by: M. M. Vasilyeva, et al.
Published: (2019-02-01)

Morphological evaluation of rentgenendovaskular interventions for cervical cancer
by: A. V. Vazhenin, et al.
Published: (2014-07-01)

COMBINED TREATMENT OF A PATIENT WITH A TESTICULAR GERM CELL TUMOR WITH SIGNS OF MULTIPLE ORGAN FAILURE
by: T. V. Ustinova, et al.
Published: (2019-09-01)

CANCER-EMBRYONIC ANTIGEN IN PREDICTING THERAPEUTIC TUMOR PATHOMORPHISM AFTER NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH RECTAL CANCER
by: D. V. Erygin, et al.
Published: (2018-06-01)

Pathomorphism in early forms of syphilis today
by: Bakulev A.L., et al.
Published: (2012-06-01)

Peculiarities of the distribution and expression dynamics of apoptosis marker Bax in patients with rectal cancer under the influence of neoadjuvant chemoradiotherapy with the usage of nitric oxide precursor
by: V. V. Golotyuk
Published: (2015-08-01)

Identification of risk factors of prostate adenocarcinoma recurrence after HIFU therapy using immunohistochemical markers
by: Popkov V.M., et al.
Published: (2014-12-01)

Neurosyphilis: problems of diagnostics and classification
by: Kolokolov O.V., et al.
Published: (2010-09-01)

Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer
by: Tal Flieswasser, et al.
Published: (2020-06-01)

Morphological features of the simulated gunshot wounds of rabbits’ soft tissues at different temperatures of injuring object
by: R.N. Mikhaylusov, et al.
Published: (2021-03-01)

Heart and longevity — clinical and instrumental features
by: L. I. Malinova, et al.
Published: (2011-10-01)

Prognostic role of beclin-1 in locally advanced non-small cell lung cancer in patients receiving docetaxel-platinum induction chemotherapy
by: Hee Yeon Lee, et al.
Published: (2019-03-01)

The Long-Term Outcomes of Induction Chemoradiotherapy Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer
by: Hidetaka Uramoto, et al.
Published: (2014-10-01)

Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells
by: Linda Sooman, et al.
Published: (2017-11-01)

Before or After: Evolving Neoadjuvant Approaches to Locally Advanced Non-Small Cell Lung Cancer
by: Jennifer Lewis, et al.
Published: (2018-01-01)

The value of neuroendocrine markers for response to therapy and survival in patients with advanced non-small cell lung cancer
by: Petrović Marina, et al.
Published: (2010-01-01)

Chemoresistance factors in non-small cell lung cancer
by: А. I. Shevchenko, et al.
Published: (2016-04-01)

Clinicopathological characteristics and treatment outcome in small cell lung cancer: A single institutional experience from India
by: Sandip Ganguly, et al.
Published: (2020-01-01)

Evolution of Tick-Borne Encephalitis over an 80-year Period: Main Manifestations, Probable Causes
by: N. M. Kolyasnikova, et al.
Published: (2020-07-01)

K-ras mutation predictive significance in platinum based chemotherapeutic protocols in patients with advanced non-small cell lung cancer
by: Cvetković Gordana, et al.
Published: (2009-01-01)

Effect of Chemotherapeutic Treatment Schedule on a Tissue Transport Model
by: Ganz, Dan E
Published: (2014)

Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma
by: Diego Cortinovis, et al.
Published: (2021-03-01)

The Clinical Efficacy and Safety of Four-Weekly Docetaxel as First-Line Therapy in Elderly Lung Cancer Patients with Squamous Cell Carcinoma
by: Jong Hyun Choi, M.D., et al.
Published: (2019-07-01)

Retrospective study of the efficacy and toxicity of lobaplatin‐etoposide chemotherapy in small cell lung cancer
by: Liyan Gu, et al.
Published: (2019-02-01)

Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer
by: Sarah-Louise Ryan, et al.
Published: (2021-03-01)

Cardiotoxic effects of chemotherapeutical treatment in oncological patient
by: D. P. Kotova, et al.
Published: (2019-04-01)

Treatment for small-cell lung cancer
by: Saadeen Ahmed, et al.
Published: (2008-10-01)